Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on June 16, 2025

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S.

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S.

Korea Zinc Co., Ltd., (Korea Zinc) will make a strategic equity investment in TMC of $85.2 million in exchange for 19.6 million common shares at the last market closing price of $4.34 per share Investment includes a three-year warrant to purchase 6.9 …

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health …

Actelis Networks Accelerates US Federal Government and Military Expansion Efforts, Hires Industry Veteran Sales Director as Company accelerates efforts in Major Military Branches

Actelis Networks Accelerates US Federal Government and Military Expansion Efforts, Hires Industry Veteran Sales Director as Company accelerates efforts in Major Military Branches

FREMONT, Calif, June 16, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that it is …

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

SINGAPORE, June 16, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today …

N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage

N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage

Neve Yarak, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable and innovative solutions for solar energy and agri-tech markets, today announced plans to …

Gold Digging and Baby Trapping 101 Book Launches July 1 from The Bloodline Alliance

Gold Digging and Baby Trapping 101 Book Launches July 1 from The Bloodline Alliance

SAN FRANCISCO, June 16, 2025 (GLOBE NEWSWIRE) -- Preorder data doesn’t lie: the very predators Grave Robbers and Gold Diggers was written to expose are outbuying men 4 to 1. So The Bloodline Alliance did the unthinkable — they handed those predators the …

Shiplify and Trinity Logistics Honored with 2025 Top Supply Chain Project Award

Shiplify and Trinity Logistics Honored with 2025 Top Supply Chain Project Award

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, has been recognized by Supply …

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the U.S. …

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from June 9, 2025 to June 13, 2025 AMSTERDAM – June 16, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

Changes in Nokia Corporation's own shares

Changes in Nokia Corporation's own shares

Nokia Corporation Stock Exchange Release 16 June 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 289 221 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Nokia Oyj Pörssitiedote 16.6.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 289 221 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

GLP-1/GIP receptor co-agonist designed to be highly potent and for once-monthly administration based on MBX’s novel PEP™ platform technology Phase 1 trial of MBX 4291 is expected to initiate in Q3 2025 CARMEL, Ind., June 16, 2025 (GLOBE NEWSWIRE) -- MBX …

Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy

Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced …

SUNation Energy Retains Nasdaq Listing

SUNation Energy Retains Nasdaq Listing

RONKONKOMA, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that, by a …

Quantic X-Microwave Launches Newly Enhanced Layout Tool for RF Designers

Quantic X-Microwave Launches Newly Enhanced Layout Tool for RF Designers

AUSTIN, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Quantic X-Microwave®, a business of Quantic Electronics® (“Quantic”) and leading provider of RF …

Monarch Private Capital Releases 2024 Impact Report: “Touchpoints”

Monarch Private Capital Releases 2024 Impact Report: “Touchpoints”

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Monarch Private Capital (Monarch), a nationally recognized impact investment firm that develops, finances, and manages a diversified portfolio of projects generating both federal and state tax credits, is proud to …

HII Selected for U.S. Army’s Live Training Contract

HII Selected for U.S. Army’s Live Training Contract

MCLEAN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Mission Technologies division is among the companies included on a multiple award contract to provide live training solutions to the U.S. Army’s Program Executive Office for Simulation, …

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce injectable G …

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

End of Phase 2 Meeting has been Rescheduled for July 29th Meeting to Discuss Upcoming Clinical Development Plan and Protocol Designs Strategic Partnership Discussions Expected to Accelerate Following a Positive FDA Meeting GLEN ALLEN, Va., June 16, 2025 ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service